Literature DB >> 24507558

Prevalence of chronic obstructive pulmonary disease in the Canary Islands.

Carlos Cabrera López1, Gabriel Juliá Serdá2, Cristina Cabrera Lacalzada3, Ana Martín Medina3, José Antonio Gullón Blanco4, Miguel Ángel García Bello5, Pedro Cabrera Navarro2.   

Abstract

INTRODUCTION: The prevalence of chronic obstructive pulmonary disease (COPD) varies significantly among the different geographical areas reported. In Spain, two epidemiological studies have shown a prevalence of 9-10% in the population aged over 40. However, neither of these studies included the Canary Islands, which are of interest due to their climatic conditions and high incidence of smoking.
MATERIALS AND METHODS: A random group of 1,353 subjects aged between 40 and 70years was selected from a sample population of 596,478 individuals. Participants completed a questionnaire and then performed spirometry with bronchodilator testing if obstruction was observed. COPD was diagnosed when the post-bronchodilator FEV1/FVC ratio was less than 0.70.
RESULTS: The prevalence of COPD was 7.3% (95%CI: 5.5-9.5) and was higher in males than in females (8.7% vs. 6.3%, P=.134). The incidence of smoking was 29.4% (95%CI: 25.4-33.1) and was also higher in males than in females (35.1% vs 25.4%, P<.001). The prevalence of COPD stratified by severity of obstruction, according to the GOLD criteria, was 16% in groupi, 69.9% in groupii, 10.4% in groupiii and 3.3% in groupiv. 71.6% of the subjects were underdiagnosed and 63.5% undertreated.
CONCLUSIONS: Despite having one of the highest rates of smoking in Spain, the prevalence of COPD in the Canary Islands is lower than in most of the Spanish regions studied.
Copyright © 2013 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Enfermedad pulmonar obstructiva crónica; Factores de riesgo; Prevalence; Prevalencia; Risk factors; Smoking; Tabaquismo

Mesh:

Year:  2014        PMID: 24507558     DOI: 10.1016/j.arbres.2013.12.006

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

Review 1.  Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations.

Authors:  Jose Luis Lopez-Campos; Luis Jara-Palomares; Xavier Muñoz; Víctor Bustamante; Esther Barreiro
Journal:  Ann Thorac Med       Date:  2015 Apr-Jun       Impact factor: 2.219

2.  Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.

Authors:  Carlos Cabrera; Ciro Casanova; Yolanda Martín; Virginia Mirabal; María Del Carmen Sánchez; Felisa Álvarez; Gabriel Juliá; Pedro Cabrera-Navarro; Miguel Ángel García-Bello; José María Marín; Juan Pablo de-Torres; Miguel Divo; Bartolomé Celli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-08

3.  Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.

Authors:  Ignacio Blanco; Isidro Diego; Patricia Bueno; Eloy Fernández; Francisco Casas-Maldonado; Cristina Esquinas; Joan B Soriano; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

4.  Prevalence of Chronic Obstructive Pulmonary Disease in an Urban Area. Changes in COPD Ten Years on.

Authors:  Elena García Castillo; Tamara Alonso Pérez; Adrián Peláez; Patricia Pérez González; Joan B Soriano; Julio Ancochea
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-29

5.  Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, Russia.

Authors:  Ivan P Artyukhov; Irina L Arshukova; Elena A Dobretsova; Tatyana A Dugina; Andrey V Shulmin; Irina V Demko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-02

Review 6.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.